Impact of docetaxel on quality of life (QoL) in elderly and non-elderly metastatic castration-resistant prostate cancer (mCRPC) patients (Pts)

Por: Rubio-Novella, S, Montes, A, Perez, I, Mejorada, R, Laorden, N, Castro, E, Hernandez, A, Olmos, D and Estelles, D

---

Publicada: 1 sep 2021 Ahead of Print: 1 sep 2021

---

---

Filiaciones:
Rubio-Novella, S:
 Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain

Montes, A:
 Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain

:
 Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain

Mejorada, R:
 CNIO Ctr Nacl Invest Oncol, Dept Prostate Canc Clin Res, Madrid, Spain

Laorden, N:
 Hosp Univ Princesa, Oncol Dept, Madrid, Spain

Castro, E:
 Hosp Univ Virgen de la Victoria, Dept Med Oncol, Malaga, Spain

Hernandez, A:
 Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain

Olmos, D:
 CNIO Ctr Nacl Invest Oncol, Med Oncol Dept, Madrid, Spain

Estelles, D:
 Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain